Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
A legfontosabb adatok
- Ki végzi
- Angiodynamics, Inc.
- Hol
- Lengyelország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 256 fő, tervezett
- Kezdés
- 2025. jún. 15.
- Várható befejezés
- 2028. jún.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- A regiszteradat frissítve
- 2025. szeptember 26.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a sudden blood clot in the lungs (acute pulmonary embolism) that strains the right side of the heart. Everyone gets clot removal with the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System.
- Életkor
- 18 years or older
- Nem
- All sexes
- A betegség stádiuma
- Acute pulmonary embolism with symptoms for at most 14 days. A CT scan of the lung arteries (CTPA) must show a clot in at least one main or proximal lobar pulmonary artery. RV/LV diameter ratio ≥ 1.0 on CTPA. Also at least one of: heart rate ≥ 100 BPM on ECG (not due to low blood volume, irregular heartbeat or sepsis); systolic blood pressure ≤ 110mmHg for at least 15 minutes; breathing rate > 20 breaths per minute; oxygen saturation (SpO2) < 90% (or arterial oxygen pressure < 60 mmHg) at rest on room air; known history of heart failure.
- Korábbi kezelés
- No advanced clot-clearing treatment for pulmonary embolism (such as clot-dissolving drugs, surgery or catheter treatment) within 30 days before the procedure.
- Biomarker vagy leletérték
- Blood troponin level above the upper limit of normal.
A részvétel fő kizáró okai
- Cannot take blood-thinning treatment
- Other illness with life expectancy under 1 year, or a do-not-resuscitate order
- Pregnant or breastfeeding
- Bleeding disorder or platelet count < 100,000/μL
- Clot in transit, IVC filter, need for ECMO, or recent cardiac arrest without recovery of consciousness
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Symptomatic, CTPA-proven acute PE with a maximum duration of symptoms of 14 days, showing a filling defect in at least one main or proximal lobar pulmonary artery
- RV/LV diameter ratio ≥ 1.0 assessed by CTPA
- Serum troponin levels above upper limit of normal as per hospital policy
- ≥ 18 years of age
- At least one of the following:; Electrocardiogram (ECG)-documented tachycardia with heart rate ≥ 100 BPM, not due to hypovolemia, arrhythmia or sepsis; Systolic blood pressure ≤ 110mmHg for at least 15 minutes; Respiratory rate > 20 breaths per minuted. Oxygen saturation on pulse oximetry (SpO2) < 90% (or partial arterial oxygen pressure < 60 mmHg) at rest while breathing room air; Known history of heart failure
- Willing and able to provide written informed consent prior to receiving study specific procedures
Ki nem vehet részt
- Participation in another investigational drug or device study that study may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational studies
- Any advanced reperfusion therapy for pulmonary embolism within 30 days of the index procedure (e.g lysis, surgery, catheter intervention)
- Any comorbid diagnosis consistent with a life expectancy of less than 1 year (e.g., stage 4 cancer)
- Cardiac arrest within last 14 days without documented evidence of recovery of conscious level to Glasgow Coma Scale >12
- Other medical, social, or psychological conditions that, in the opinion of the Investigator, precludes the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow- up requirements, or that could impact the scientific integrity of the study
- History of congenital or acquired bleeding disorder predisposing to hemorrhagic state
- Platelet count < 100,000/μL
- A contraindication to therapeutic anticoagulation
- Known serious, uncontrolled sensitivity to radiographic agents
- Indication for ECMO
- Pregnant or breastfeeding
- A known clot in transit
- IVC filter
- A do not resuscitate limitation at inclusion in the study
- Deprived of liberty or under court protection
Ez a vizsgálat jelenleg itt érhető el: Lengyelország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
To evaluate the efficacy, safety, and long-term functional outcomes of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System for the treatment of acute pulmonary embolism.
A vizsgálat csoportja
- Single Arm Study - Use of AngioDynamics' AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PEA vizsgált kezelés
Prospective single-arm trial reporting the efficacy, safety, and long-term functional outcomes of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System for the treatment of acute pulmonary embolism.
Kezelés: AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- A regiszteradat frissítve
- 2025. szeptember 26.